Metamizole-Induced Agranulocytosis: Utilisation Trends, Pharmacovigilance Signals and Regulatory Risk-Minimisation in Switzerland. Swiss Med Wkly 2026, 156 (6), 5062. https://doi.org/10.57187/5062.